Turnaround

After an extended period of decline, Abeona Therapeutics is demonstrating renewed momentum. The biotechnology firm is gaining traction from a...

The protracted uncertainty surrounding Thyssenkrupp's most significant challenge may finally be approaching a resolution. A new, determined bidder has emerged...

How can a company simultaneously shatter performance records while teetering on the edge of financial instability? This contradiction defines the...

The investment community is losing faith in Gerresheimer at an alarming rate. Following closely on the heels of a recent...

The investment case for artificial intelligence specialist C3.ai has deteriorated dramatically in recent months, with the company confronting its most...

The telecommunications sector is witnessing an intriguing divergence of opinion regarding T-Mobile US. While the company demonstrates robust financial health...

A class action lawsuit has placed Dow Inc under intense scrutiny, with allegations that the chemical giant misrepresented the security...

The solar technology innovator Enphase Energy is striving to mount a significant recovery. Despite surprising the market with robust quarterly...

Realty Income finds itself at a critical juncture as conflicting signals emerge from its latest financial performance. The real estate...

Despite posting consistent losses and witnessing significant insider selling, Denali Therapeutics is capturing intense market interest. The biotech firm's shares,...